URB597
From Wikipedia, the free encyclopedia
| urb597 | |
|---|---|
| Chemical name | (3'-(aminocarbonyl)[1,1'-biphenyl]-3-yl) -cyclohexylcarbamate |
| Chemical formula | C20H22N2O3 |
| Molecular mass | 338.4 g/mol |
| CAS number | 546141-08-6 |
 |
|
In pre-clinical laboratory tests researchers found URB597 increased the production of endocannabinoids by blocking their degradation, resulting in measurable antidepressant effects.
URB597 is also known as KDS-4103. KDS-4103 is being developed by Kadmus Pharmaceuticals, Inc. for clinical trials in humans. Kadmus claims, on their website (linked below) that this class of compounds may have antidepressant, anti-anxiety, and pain-killing effects.
[edit] External links
- Kadmus Pharmaceuticals official website
- Modulation of anxiety through blockade of anandamide hydrolysis in Nature
- New drug acts as marijuana in the brain at cannabis.net
- Product Information from Cayman Chemical
 |
This medical treatment article is a stub. You can help Wikipedia by expanding it. |
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
